PAR-19-222 - Small Grants for New Investigators to Promote Diversity in Health-Related Research (R21 Clinical Trial Optional)
National Human Genome Research Institute (NHGRI)
The purpose of this Notice is to alert the community that NHGRI plans to publish a Funding Opportunity Announcement (FOA) for New Investigators to Promote Workforce Diversity in Genomics and other Health-Related Research (R01 Clinical Trial Optional). This program is intended to provide funds for New Investigators from diverse backgrounds, including those from groups underrepresented in the biomedical sciences, to pursue independent research within the mission of the participating institutes and centers. .
This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects.
The FOA is expected to be published in Spring of 2021. Applications are expected to be accepted in the beginning of August 2021 for FY22 funding. .
This FOA will utilize the R01. Details of the planned FOA are provided below.
Research Initiative Details
This program will support research performed by investigators who are from diverse backgrounds, including those from underrepresented groups (as described in the NIH Diversity Statement – NOT-OD-20-031). The goal is to enhance the diversity of R01 funded investigators. Eligibility criteria includes applicants who meet the NIH criteria for New Investigator ,( https://grants.nih.gov/policy/early-investigators/index.htm), including Early Stage Investigators, a subset of New Investigators. New Investigators are investigators who have not previously competed successfully for substantial, independent funding from NIH. Early Stage Investigators are investigators who have completed their terminal research degree or end of post-graduate clinical training, whichever date is later, within the past 10 years and who have not previously competed successfully as PD/PI for a substantial NIH independent research award.
Applicants to NHGRI may propose any research topic suitable for an R01 within the NHGRI mission, as described on the NHGRI website for the Division of Genome Sciences, the Division of Genomic Medicine, and the Ethical, Legal and Social Implications Research Program..
If other ICs sign on, they will announce their criteria.
Estimated NHGRI Total Funding: $5.25M
Expected Number of NHGRI Awards: 5-7 awards/year for each of 3 years
Estimated NHGRI Award Ceiling: $500K Direct Cost limit
Applications are not being solicited at this time.
Please direct all inquiries to:
National Human Genome Research Institute (NHGRI):
Jyoti Dayal, M.S.